GOSS
GOSS
US38341P1021
Gossamer Bio, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
56.94M EUR
80.66M EUR
77.22M EUR
724.4M EUR
Enterprise Value
43.41M EUR
79.58M EUR
239.12M EUR
889.57M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-0.6x
--
--
--
Price to Sales
1.07x
1.51x
1.39x
18.78x
Price to Book
--
--
--
--
EV/Revenue
0.82x
1.49x
4.31x
23.06x
EV/EBITDA
-0.27x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-52.27%
-201.62%
-220.57%
-18.17%
ende